Drug intelligence / Profile preview

Vitamin B-complex Hevert

Development stage
Phase 3
Lead developer
Hevert-Arzneimittel
Modality
Small Molecules
Administration
Oral
01

Overview

Vitamin B-complex Hevert (brand name: Vitamin B Komplex forte Hevert) is an approved, non-prescription vitamin supplement developed and manufactured by Hevert-Arzneimittel GmbH & Co. KG, based in Nussbaum, Germany. It is a small-molecule vitamin supplement formulated as film tablets, indicated for the therapy of confirmed deficiency states of vitamins B1, B6, and B12. Each tablet contains Vitamin B1 (Thiaminnitrat) 100 mg, Vitamin B6 (Pyridoxin-HCl) 50 mg, and Vitamin B12 (Cyanocobalamin) 500 µg as active ingredients. The three B vitamins work synergistically to optimize metabolic processes in cells—particularly nerve cells—supporting nervous system function, memory, heart function, blood formation, and relief of nerve pain. It is used to treat symptoms of B-vitamin deficiency such as tingling, burning, numbness, and pain in the hands and feet (e.g., in neuropathies).

Brand names
Vitamin B Komplex forte Hevert
Other names
Vitamin B-Komplex forte Hevertthiamine + pyridoxine + cyanocobalaminvitamin B1 + vitamin B6 + vitamin B12
02

Targets

MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)OGDH (Dihydrolipoamide S-succinyltransferase)PDH (Pyruvate dehydrogenase complex)TKT (Transketolase)

Beyond the preview

Go deeper on Vitamin B-complex Hevert.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin B-complex Hevert.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call